Where world-class biotechnology meets Swiss reliability

Ticino is becoming a biotech hub

A dynamic biotech scene is taking root in the south of the Greater Zurich Area. It acts as a bridge to Italy and has impressive global ties,, which is a core characteristic of biotechnology in Switzerland as a whole. The Institute for Research in Biomedicine (IRB) in Ticino specializes in immunology and is spearheading the fight against coronavirus.

The first hire – key success factor for U.S. biotechs expanding into Europe

Positive outlook for Swiss biotech VC

Venture capital is particularly important for biotech start-ups as the road to a product is long. In Switzerland, the chances of funding are positive, according to Nadine Geiser, an investment manager at the venture capital company Redalpine Venture Partners.

Hiring and building your brand

Corona drug effective against mutation

Schlieren ZH – Studies have revealed that the two potential anti-COVID-19 drugs developed by Molecular Partners have shown a therapeutic and preventative effect against the mutations first observed in the UK and South Africa.  

Biotechs receive most venture capital

Investments in Swiss startups were down over 7 percent in 2020. At the same time, domestic biotech startups managed to secure significantly more funding than in the previous year. These are findings of the Swiss Venture Capital Report.